Journal of Rheumatic Diseases

Cited by CrossRef (19)

  1. Oh Chan Kwon, Min-Chan Park. BASDAI cut-off values corresponding to ASDAS cut-off values. 2022;61:2369
    https://doi.org/10.1093/rheumatology/keab494
  2. Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim. Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis. Sci Rep 2022;12
    https://doi.org/10.1038/s41598-022-24027-6
  3. Bon San Koo, Yu-Cheol Lim, Min-Young Lee, Ja-Young Jeon, Hyun-Jeong Yoo, In-Sun Oh, Ju-Young Shin, Tae-Hwan Kim. Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis. Rheumatol Ther 2021;8:347
    https://doi.org/10.1007/s40744-020-00274-9
  4. Yoon-Kyoung Sung. Advantages and disadvantages of targeted therapy in patients with rheumatoid arthritis. J Korean Med Assoc 2021;64:90
    https://doi.org/10.5124/jkma.2021.64.2.90
  5. Hyemin Jeong, Yong‐Gil Kim, Tae‐Hwan Kim, Tae‐Jong Kim, Min‐Chan Park, Mi Ryoung Seo, Kichul Shin, Ji Seon Oh, Sang‐Hoon Lee, Yeon‐Ah Lee, Eun Young Lee, Han Joo Baek, Hoon‐Suk Cha. Clinical characteristics of non‐radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data. Int J of Rheum Dis 2021;24:1137
    https://doi.org/10.1111/1756-185X.14175
  6. SeungCheon Yang, Hong Ki Min, Jin-Sil Park, Hyun Sik Na, Mi-La Cho, Sung-Hwan Park, Masanori A. Murayama. A green-lipped mussel prevents rheumatoid arthritis via regulation of inflammatory response and osteoclastogenesis. PLoS ONE 2023;18:e0280601
    https://doi.org/10.1371/journal.pone.0280601
  7. Tae-Han Lee, Bon San Koo, Bora Nam, Ji Seon Oh, Seo Young Park, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim. Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset. Therapeutic Advances in Musculoskeletal 2020;12
    https://doi.org/10.1177/1759720X20975912
  8. Hong Ki Min, Se Hee Kim, Sang-Heon Lee, Hae-Rim Kim. Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry. Therapeutic Advances in Musculoskeletal 2024;16
    https://doi.org/10.1177/1759720X231218098
  9. Bon San Koo, Tae-Hwan Kim. The role of ixekizumab in non-radiographic axial spondyloarthritis. Therapeutic Advances in Musculoskeletal 2021;13
    https://doi.org/10.1177/1759720X20986734
  10. Hong Ki Min, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee. Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis. IJMS 2022;23:13913
    https://doi.org/10.3390/ijms232213913
  11. Oh Chan Kwon, Jung Hwan Park, Min-Chan Park. Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor. Therapeutic Advances in Musculoskeletal 2021;13
    https://doi.org/10.1177/1759720X211009021
  12. Bora Nam, Bon San Koo, Nayeon Choi, Ji-Hui Shin, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim. The impact of smoking status on radiographic progression in patients with ankylosing spondylitis on anti-tumor necrosis factor treatment. Front. Med. 2022;9
    https://doi.org/10.3389/fmed.2022.994797
  13. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate. Z Rheumatol 2023;82:248
    https://doi.org/10.1007/s00393-021-01041-z
  14. Yun-Hee Han, Hyeon-Jun Woo, Soo-Yeon Park, Chang-Hoon Lee, Chong-Hyuk Chung, Myeung-Su Lee, Jung-Han Lee. Korean Domestic Trends in Clinical Research on Rheumatoid Arthritis since 2008. J Korean Med Rehabil 2021;31:18
    https://doi.org/10.18325/jkmr.2021.31.3.19
  15. Hong Ki Min, Hae-Rim Kim, Sang-Heon Lee, Bora Nam, Ji Hui Shin, Tae-Hwan Kim. Risk of disease flare in spondyloarthritis patients after tapering tumor necrosis factor inhibitors: A meta-analysis and literature review. International Immunopharmacology 2024;134:112167
    https://doi.org/10.1016/j.intimp.2024.112167
  16. Soo-Kyung Cho, Yoon-Kyoung Sung. Treatment strategy for patients with rheumatoid arthritis. J Korean Med Assoc 2020;63:422
    https://doi.org/10.5124/jkma.2020.63.7.422
  17. Hong Ki Min, Hyeongsu Kim, Ho Jin Jeong, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, KunSei Lee, Soon-Ae Shin, Jong Heon Park. Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data. Epidemiol Health 2023;45:e2023045
    https://doi.org/10.4178/epih.e2023045
  18. Yue Hu, Yunze Han, Yan Ma, Shumei Fan, Xue Wang, Xinyu Fu, Xiaopeng Hu, Xufei Luo, Yanfang Ma, Yangqin Xun, Nan Yang, Chengping Wen, Wei Cao, Xuping Song, Yaolong Chen. Consistency of recommendations for pharmacotherapy of rheumatoid arthritis. Front. Pharmacol. 2022;13
    https://doi.org/10.3389/fphar.2022.967787
  19. Mirza Muhammad Faran Ashraf Baig, Chi Hin Kwan, Hongkai Wu, Sek Ying Chair. The etiology, pathogenesis, treatment, and development of transdermal drug delivery systems for rheumatoid arthritis. RSC Pharm. 2024;1:592
    https://doi.org/10.1039/D4PM00085D